Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5170328 | 1.00 | ALDH1A1 (0.46) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL5169748 | 1.00 | ALDH1A1 (0.46) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL6950290 | 0.85 | ALDH1A1 (0.45) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL6947458 | 0.85 | ALDH1A1 (0.45) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL8603114 | 0.83 | HPGD (0.47) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL27686290 | 0.83 | CPA1 (0.45) | ALDH1A1NPC1RAB9AHPGDCYP1A2 | |
| SCHEMBL6330627 | 0.83 | CPA1 (0.45) | ALDH1A1NPC1RAB9AHPGDCYP1A2 | |
| SCHEMBL6946975 | 0.83 | HPGD (0.47) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL6950840 | 0.83 | HPGD (0.47) | ALDH1A1HTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL8202673 | 0.82 | CYP1A2 (0.53) | HPGDCYP1A2ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070129443-A1 | Production method of aminochlorohydrin sulfate | AJINOMOTO CO., INC. (JP) | 2007-06-07 | — | — | US | claimed |
| EP-1777213-A1 | Production method of aminochlorohydrin sulfate | Ajinomoto Co., Inc. (JP) | 2007-04-25 | — | — | EP | claimed |
| US-20070129443-A1 | Production method of aminochlorohydrin sulfate | AJINOMOTO CO., INC. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070129443-A1 | Production method of aminochlorohydrin sulfate | AJINOMOTO CO., INC. (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20070129443-A1 | Production method of aminochlorohydrin sulfate | AJINOMOTO CO., INC. (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1777213-A1 | Production method of aminochlorohydrin sulfate | Ajinomoto Co., Inc. (JP) | 2007-04-25 | — | — | EP | disclosed |
| EP-1777213-A1 | Production method of aminochlorohydrin sulfate | Ajinomoto Co., Inc. (JP) | 2007-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129443-A1 | Production method of aminochlorohydrin sulfate | TST, ALDH7A1, HACL2 | ALDH1A1 394/4885HTT 287/4885SMN1; SMN2 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.